(Q40024883)

16 September 2017

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma (English)

1 reference

16 September 2017

0 references

0 references

0 references

Y Shi

1

1 reference

16 September 2017

M Zou

2

1 reference

16 September 2017

E Y Baitei

3

1 reference

16 September 2017

A S Alzahrani

4

1 reference

16 September 2017

R S Parhar

5

1 reference

16 September 2017

Z Al-Makhalafi

6

1 reference

16 September 2017

F A Al-Mohanna

7

1 reference

16 September 2017

21 December 2007

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

2

1 reference

16 September 2017

101-107

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701101

16 September 2017

0 references

cites work

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Gene therapy for thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cytokine gene therapy: hopes and pitfalls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Human cancer gene therapy with cytokine gene-modified cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Gene therapy of cancer based on interleukin 12.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoids: potential anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoids and cancer: pros and cons of an antitumour strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Targeting the endocannabinoid system in cancer therapy: a call for further research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoid receptor as a novel target for the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoid receptors as novel targets for the treatment of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701101

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701101

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference